Rezolute Inc RZLT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
3.31quote price arrow up+0.34 (+11.45%)
Volume
333,906
52 week range
0.72 - 3.69
Loading...
  • Open2.98
  • Day High3.38
  • Day Low2.98
  • Prev Close2.97
  • 52 Week High3.69
  • 52 Week High Date04/22/24
  • 52 Week Low0.72
  • 52 Week Low Date11/30/23

Key Stats

  • Market Cap132.823M
  • Shares Out40.13M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta1.22
  • YTD % Change233.5

KEY STATS

  • Open2.98
  • Day High3.38
  • Day Low2.98
  • Prev Close2.97
  • 52 Week High3.69
  • 52 Week High Date04/22/24
  • 52 Week Low0.72
  • 52 Week Low Date11/30/23
  • Market Cap132.823M
  • Shares Out40.13M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta1.22
  • YTD % Change233.5

RATIOS/PROFITABILITY

  • EPS (TTM)-1.11
  • P/E (TTM)-2.99
  • Fwd P/E (NTM)-2.72
  • EBITDA (TTM)-62.448M
  • ROE (TTM)-48.79%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Rezolute Inc

 

Profile

MORE
Rezolute, Inc. is a clinical-stage biopharmaceutical company, which is developing therapies for metabolic diseases related to chronic glucose imbalance. The Company’s lead clinical asset, RZ358, is in late-stage development for the treatment of congenital hyperinsulinism (HI), an ultra-rare pediatric genetic disorder characterized by excessive production of insulin by the pancreas in Phase III. RZ358 is an intravenously administered human monoclonal antibody that binds to a...
Nevan Elam J.D.
Acting Chairman of the Board, Chief Executive Officer
Daron Evans
Chief Financial Officer
Address
275 Shoreline Drive, Suite 500
Redwood City, CA
94065
United States

Top Peers

SYMBOLLASTCHG%CHG
LIFE
aTyr Pharma Inc
1.61+0.01+0.62%
IMUX
Immunic Inc
1.37+0.04+3.01%
OTLK
Outlook Therapeutics Inc
8.60+0.10+1.18%
ANIX
Anixa Biosciences Inc
2.94-0.03-1.01%
VIGL
Vigil Neuroscience Inc
3.03+0.29+10.58%